Lilly, Indiana
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.
Eli Lilly to build $4.5 billion Indiana facility for advanced drug manufacturing
Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027.
Lilly to invest $4.5 bln on new Indiana facility
U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and drug development in Indiana.
Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
Eli Lilly is pouring another $4.5 billion into expanding manufacturing and development as the drugmaker rakes in billions from new product sales. The diabetes treatment maker said Wednesday that it will build a new center for advanced manufacturing and drug development a few miles from its Indianapolis headquarters.
Eli Lilly is building a $4.5 billion factory to speed up drug production
Pharmaceutical giant Eli Lilly (LLY) is putting $4.5 billion toward building a new site to develop and manufacture drugs.
Lilly to invest $4.5 billion on new facility to scale-up pipeline drug production
U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center in Indiana that will focus on developing new ways to manufacture its drugs and increasing production of experimental medicines used in clinical studies.
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making ...
Lilly's weight-loss drug removed from FDA's shortage list
Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...
Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...
England's NHS to offer Lilly's weight-loss drug to some patients
England's National Health Services plans to offer Eli Lilly's weight-loss drugs to nearly a quarter million people as part of ...
FiercePharma2d
Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
Lilly Pulitzer unveils sixth annual collection for Breast Cancer Research Foundation
It's the largest Print with a Purpose collection ever from the Palm Beach brand, to benefit an organization with strong ties ...
Altoona Mirror1d
Lilly man killed in collision with bus
From Mirror staff reports An 18-year-old Lilly man was killed in a crash Thursday morning in Cambria County. Cambria County Coroner Jeff Lees said David Swinger died instantly from massive chest ...
fox17online2d
From patient to practitioner: Lilly’s journey with Aplastic Anemia
Lilly VandenBosch is in the process of becoming a nurse practitioner after living through a childhood battling the rare blood ...
Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...
Lilly Shells Out $4.5 Billion for New Drug Development Plant
Eli Lilly & Co. is pouring $4.5 billion into a new manufacturing plant in Indiana to make drugs for future clinical trials, ...